Works by Lin, Bi-Zhen


Results: 6
    1
    2
    3

    Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial.

    Published in:
    Human Vaccines & Immunotherapeutics, 2022, v. 18, n. 6, p. 1, doi. 10.1080/21645515.2022.2092363
    By:
    • Mo, Zhao-Jun;
    • Bi, Zhao-Feng;
    • Sheng, Wei;
    • Chen, Qi;
    • Huang, Teng;
    • Li, Ming-Qiang;
    • Cui, Xue-Lian;
    • Wangjiang, Ya-Hui;
    • Lin, Bi-Zhen;
    • Zheng, Feng-Zhu;
    • Sun, Guang;
    • Li, Ya-Fei;
    • Zheng, Ya;
    • Zhuang, Si-Jie;
    • Su, Ying-Ying;
    • Pan, Hui-Rong;
    • Huang, Shou-Jie;
    • Wu, Ting;
    • Zhang, Jun;
    • Xia, Ning-Shao
    Publication type:
    Article
    4
    5
    6